InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
69%
T+90 mean return
+9.9%
Across 35 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Gilliam Joseph E, Chief Operating Officer. Director active across 1 company, notably GLAUKOS Corp. Aggregated, 50 filings have been recorded. Activity tracked since 3 May 2021. The latest transaction was filed on 21 January 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations50 total
1,056 sharesCommon StockSEC:0001705850-26-000020:0
4,502 shares@ US$55.180.0033% mcap8.9% of flowCommon StockSEC:0001705850-26-000002:0
4,502 shares@ US$55.188.9% of flowCommon StockSEC:0001705850-26-000002
1,057 shares@ US$96.970.8% of flowCommon StockSEC:0001415889-25-015022:0
1,922 shares@ US$97.091.5% of flowCommon StockSEC:0001415889-25-009798:0
13,429 shares@ US$107.6111.5% of flowCommon StockSEC:0001415889-25-009125:0
3,888 shares0Common StockSEC:0001415889-25-008254:0
964 shares@ US$138.931.1% of flowCommon StockSEC:0001415889-25-000248:0
1,053 shares@ US$39.100.3% of flowCommon StockSEC:0001415889-24-030120:0
2,275 shares@ US$69.301.3% of flowCommon StockSEC:0001415889-24-025918:0
2,500 shares@ US$55.181.1% of flowCommon StockSEC:0001415889-24-022146:0
2,250 shares@ US$69.301.2% of flowCommon StockSEC:0001415889-24-019438:0
2,500 shares@ US$55.181.1% of flowCommon StockSEC:0001415889-24-015681:0
2,395 shares@ US$55.181.1% of flowCommon StockSEC:0001415889-24-013136:0
105 shares@ US$55.180.0% of flowCommon StockSEC:0001415889-24-012635:0
2,059 shares@ US$69.301.1% of flowCommon StockSEC:0001415889-24-012358:0
59,801 shares@ US$41.6919.8% of flowCommon StockSEC:0001415889-24-010674:0
2,457 shares@ US$55.181.1% of flowCommon StockSEC:0001415889-24-010612:0
200 shares@ US$55.180.1% of flowCommon StockSEC:0001415889-24-010452:0
1,964 shares@ US$93.101.5% of flowCommon StockSEC:0001415889-24-010196:0
2,615 shares@ US$88.081.8% of flowCommon StockSEC:0001415889-24-009549:0
3,886 shares0Common StockSEC:0001415889-24-008358:0
26,671 shares@ US$39.108.3% of flowCommon StockSEC:0001415889-24-005638:0
1,512 shares@ US$55.180.7% of flowCommon StockSEC:0001415889-24-003767:0
5,000 shares@ US$39.101.6% of flowCommon StockSEC:0001415889-24-003420:0
25 of 50 declarations
About Gilliam Joseph E
Joseph E. Gilliam is President and Chief Operating Officer of Glaukos Corporation. Glaukos said he joined the company in May 2017 as Chief Financial Officer and Senior Vice President, Corporate Development, after serving as a managing director in J.P. Morgan’s healthcare investment banking group, where he led Glaukos’s initial public offering. The company also said he was promoted to President and Chief Operating Officer effective April 1, 2022, and that he serves on the board of directors and audit committee of Caris Life Sciences. Sources : https://www.sec.gov/Archives/edgar/data/1192448/000155837023006164/gkos-20230601xdef14a.htm
